Replacing insulin with immunotherapy: Time for a paradigm change in Type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Replacing insulin with immunotherapy: Time for a paradigm change in Type 1 diabetes

Published:2021-09-29 Issue:12 Volume:38 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Tatovic Danijela¹,Dayan Colin M¹

Affiliation:

1. Diabetes and Autoimmunity Research Group Cardiff University School of Medicine Cardiff UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14696

Reference48 articles.

1. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

2. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

3. Excess all-cause mortality before age 30 in childhood onset type 1 diabetes: data from the Brecon Group Cohort in Wales

4. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

5. Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial;Nature Medicine;2024-07-30

2. Multi‐omics analysis reveals drivers of loss of β‐cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study;Diabetes/Metabolism Research and Reviews;2024-07

3. HLA Genotyping in Children With Celiac Disease Allows to Establish the Risk of Developing Type 1 Diabetes;Clinical and Translational Gastroenterology;2024-05-07

4. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy;ImmunoTargets and Therapy;2023-09

5. Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA^‡multicenter study;2023-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3